Increased plasma homocysteine levels in multiple sclerosis

Abstract

Get full access to this article

View all access options for this article.

References

Seshadri S. , Beiser A. , Selhub J. , Jacques PF , Rosenberg IH , D'Agostino RB , et al . Plasma homocysteine as a risk flactor flor dementia and Alzheimer's disease. N Engl J Med 2002; 346: 476 - 83.

Baig Sm , Qureshi G. Homocysteine and vitamin B12 in multiple sclerosis. Biogen Amines 1995; 11: 479 - 85.

Ashtari F. , Salehi Abari Sh , Shaygan Nejad V. Serum homocysteine level in patients with multiple sclerosis. JRMS 2005; 10: 302-304.

Ramsaransing GS , Fokkema MR , Teelken A. , Arutjunyan AV , Koch M. , De Keyser J. Plasma homocysteine levels in multiple sclerosis . J Neurol Neurosurg Psychiatry 2006; 77(2): 189-92.

Vrethem M. , Mattsson E. , Hebelka H. , Leerbeck K. , Osterberg A. , Landtblom AM , et al . Increased plasma homocysteine levels without signs ofl vitamin B12 deficiency in patients with multiple sclerosis assessed by blood and cerebrospinal fluid homocysteine and methylmalonic acid. Mult Scler 2003; 9: 239 - 45.

Turk Boru U, Alp R, Sur H, Gul L. Prevalence ofl multiple sclerosis door-to-door survey in Maltepe, Istanbul, Turkey. Neuroepidemiology 2006; 27: 17-21.

Nilsson-Ehle H. Age-related changes in cobalamin (vitamin B12) handling. Implications flor therapy. Drugs Aging 1998; 12: 277-92.

Krumdieck CL , Prince CW Mechanisms ofl homocysteine toxicity on connective tissues: implications flor the morbidity ofl aging. J Nutr 2000; 130: 365-68.

Jakubowski H. Homocysteine thiolactone: metabolic origin and protein homocysteinylation in humans. J Nutr 2000; 130: 377-81.

10.

Au-Yeung Kkw , Woo Cwh , Sung FL, Yip JCW, Siow YL, OK. Hyperhomocysteinemia activates nuclear flactor-kappa B in endothelial cells via oxidative stress . Circ Res 2004; 94: 28-36.